Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1965231

Cover Image

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1965231

Philippines Medical Tourism Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2026 - 2032)

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 1800
Printable PDF (Group User License)
USD 2700
Printable PDF (Enterprise License)
USD 4000

Add to Cart

The Philippines medical tourism market was valued at USD 1,530.0 million in 2025 and is projected to reach USD 3,418.5 million by 2032, expanding at a compound annual growth rate of 12.2% from 2026 through 2032, according to PS Market Research. This growth is underpinned by the country's combination of cost competitive, high quality healthcare services, internationally accredited facilities, and strategic government initiatives that promote medical travel and wellness integrated care. These factors are attracting international patients seeking affordable elective procedures, specialized treatments, and post treatment recuperation in a culturally welcoming environment, reinforcing the Philippines' position as a significant destination in the Asia Pacific medical tourism landscape.

Key Insights

Treatment Demand: Cosmetic surgery was the largest category in 2025, with a roughly 35% share, driven by the reputation of Filipino plastic surgeons and bundled medical leisure packages that attract patients from East Asia, North America, and the Middle East. Fertility treatments are expected to be the fastest growing segment as demand for in vitro fertilization (IVF) services increases among international patients.

Service Provider Outlook: Hospitals held the largest share at about 65% in 2025 due to their broader range of specialties and international accreditations, while clinics are the fastest growing provider category as they specialize in high demand, cost efficient services such as cosmetic, dental, and fertility care.

Patient Demographics: Female patients accounted for the largest share in 2025 at around 60%, with rising demand among male patients projected over the forecast period as interest in aesthetic and preventive health services grows. Older age groups, especially above 60 years, are driving demand for orthopedic and chronic disease related treatments.

Regional Dynamics: Metro Manila (NCR) dominated the market in 2025 with about 45% revenue share, reflecting its concentration of internationally accredited hospitals and established healthcare infrastructure. CALABARZON is the fastest growing regional market as expanding medical facilities and improved access continue to draw international patients.

Market Structure: The medical tourism market is moderately consolidated, with leading hospital networks, specialty centers, and medical tourism facilitators competing to provide comprehensive care and international patient services, supported by strong referral networks and accreditation credentials.

Market Dynamics: Growth is propelled by the cost advantage of medical procedures that are 40-80% lower than in many Western countries, the proficiency of English speaking medical professionals, and government initiatives like the Filipino Brand of Wellness that integrate clinical and holistic recovery experiences. At the same time, competition from established regional medical tourism hubs and the need for ongoing infrastructure enhancements remain considerations for market participants.

Product Code: 13940

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market Size Breakdown, by Treatment Type
    • 1.4.2. Market Size Breakdown, by Service Provider
    • 1.4.3. Market Size Breakdown, by Patient Gender
    • 1.4.4. Market Size Breakdown, by Age Group
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Revenue
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence Database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Industry Background
  • 5.2. Market Dynamics
    • 5.2.1. Trends
    • 5.2.2. Drivers
    • 5.2.3. Restraints/Challenges
    • 5.2.4. Emerging Economies and Key Opportunities
    • 5.2.5. Impact Analysis of Drivers/Restraints
  • 5.3. Sociopolitical Impact
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Bargaining Power of Buyers
    • 5.4.2. Bargaining Power of Suppliers
    • 5.4.3. Threat of New Entrants
    • 5.4.4. Intensity of Rivalry
    • 5.4.5. Threat of Substitutes
  • 5.5. Lifecycle Analysis
  • 5.6. Innovation and Technology Trends
  • 5.7. Economic and Regulatory Impact
  • 5.8. Market Entry Strategies

Chapter 6. Competitive Landscape

  • 6.1. List of Market Players and their Offerings
  • 6.2. Market Share of Key Players (2025)
  • 6.3. Competitive Benchmarking of Key Players
  • 6.4. Product Benchmarking of Key Players
  • 6.5. Recent Strategic Developments by Key Players
  • 6.6. Company Leadership Matrix

Chapter 7. Manila Metro (NCR) Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Treatment Type (2021-2032)
  • 7.3. Market Revenue, by Service Provider (2021-2032)
  • 7.4. Market Revenue, by Patient Gender (2021-2032)
  • 7.5. Market Revenue, by Age Group (2021-2032)
  • 7.6. Market Revenue, by Country (2021-2032)

Chapter 8. CALABARZON Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Treatment Type (2021-2032)
  • 8.3. Market Revenue, by Service Provider (2021-2032)
  • 8.4. Market Revenue, by Patient Gender (2021-2032)
  • 8.5. Market Revenue, by Age Group (2021-2032)
  • 8.6. Market Revenue, by Country (2021-2032)

Chapter 9. Central Visayas Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Treatment Type (2021-2032)
  • 9.3. Market Revenue, by Service Provider (2021-2032)
  • 9.4. Market Revenue, by Patient Gender (2021-2032)
  • 9.5. Market Revenue, by Age Group (2021-2032)
  • 9.6. Market Revenue, by Country (2021-2032)

Chapter 10. MIMAROPA Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Treatment Type (2021-2032)
  • 10.3. Market Revenue, by Service Provider (2021-2032)
  • 10.4. Market Revenue, by Patient Gender (2021-2032)
  • 10.5. Market Revenue, by Age Group (2021-2032)
  • 10.6. Market Revenue, by Country (2021-2032)

Chapter 11. Davao Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Treatment Type (2021-2032)
  • 11.3. Market Revenue, by Service Provider (2021-2032)
  • 11.4. Market Revenue, by Patient Gender (2021-2032)
  • 11.5. Market Revenue, by Age Group (2021-2032)
  • 11.6. Market Revenue, by Country (2021-2032)

Chapter 12. Central Luzon Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Treatment Type (2021-2032)
  • 12.3. Market Revenue, by Service Provider (2021-2032)
  • 12.4. Market Revenue, by Patient Gender (2021-2032)
  • 12.5. Market Revenue, by Age Group (2021-2032)
  • 12.6. Market Revenue, by Country (2021-2032)

Chapter 13. Northern Mindanao Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Treatment Type (2021-2032)
  • 13.3. Market Revenue, by Service Provider (2021-2032)
  • 13.4. Market Revenue, by Patient Gender (2021-2032)
  • 13.5. Market Revenue, by Age Group (2021-2032)
  • 13.6. Market Revenue, by Country (2021-2032)

Chapter 14. Company Profiles

Chapter 15. Appendix

  • 15.1. Sources and References
  • 15.2. Related Reports
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!